Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

NBTX · Insider trading · 13F holders · Congress trades

Nanobiotix (NBTX)

Who is buying and selling NBTX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.

13F filers holding
1
Insider buys, 90 days
$0
Insider sales, 90 days
$0
Congress trades, 12 months
0

NBTX at a glance

  • No open-market insider purchases or sales of NBTX were filed in the last 90 days.
  • 1 13F filer hold NBTX among their 50 largest positions, worth $175.2M combined. The biggest bets by portfolio weight are Johnson & Johnson (23.0%).
  • No member of Congress has disclosed a trade in NBTX.

NBTX insider trading

No open-market insider purchases or sales of NBTX were filed in the last 90 days.

Who owns NBTX? Hedge funds and superinvestors

1 13F filer hold NBTX among their 50 largest positions, worth $175.2M combined. The biggest bets by portfolio weight are Johnson & Johnson (23.0%).

13F filers holding NBTX
Manager% of portfolioValueSharesLast quarter13F
Johnson & JohnsonCorporation23.0%$175.2M5,623,816+0.0% sharesQ3 2026

Each manager counts with its latest 13F (Q3 2026: 1). Screen NBTX in the grand portfolio →

NBTX stock trades by members of Congress

No member of Congress has disclosed a trade in NBTX.

NBTX questions and answers

Are insiders buying NBTX stock?

No open-market insider purchases or sales of NBTX were filed in the last 90 days.

Which hedge funds own NBTX?

1 13F filer hold NBTX among their 50 largest positions, worth $175.2M combined. The biggest bets by portfolio weight are Johnson & Johnson (23.0%).

Has Congress traded NBTX?

No member of Congress has disclosed a trade in NBTX.

Who is the largest holder of NBTX?

Among 13F filers, Johnson & Johnson reports the largest NBTX position, $175.2M (5,623,816 shares) in its Q3 2026 13F. The biggest bet by portfolio weight is Johnson & Johnson's: 23.0% of its portfolio.

Cite or share this

Free to use with a link back. The data updates every filing day.

Citation
Link